These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37954563)

  • 1. Antiarrhythmic effects of baroreceptor activation therapy in chronic heart failure: a case report.
    Wang D; Veltmann C; Bauersachs J; Duncker D
    Eur Heart J Case Rep; 2023 Nov; 7(11):ytad520. PubMed ID: 37954563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to the treatment of advanced heart failure: a case report.
    Robles-Mezcua A; Villaescusa-Catalán JM; Melero-Tejedor JM; García-Pinilla JM
    Eur Heart J Case Rep; 2021 Feb; 5(2):ytaa541. PubMed ID: 33738406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single-centre experience.
    Blanco C; Madej T; Mangner N; Hommel J; Grimm S; Knaut M; Linke A; Winzer EB
    ESC Heart Fail; 2023 Dec; 10(6):3373-3384. PubMed ID: 37667319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
    Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
    Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpharmacologic Treatment for Heart Failure: A Review of Implantable Carotid Baroreceptor Stimulators As a Therapeutic Option.
    Malangu B; Lanier GM; Frishman WH
    Cardiol Rev; 2021; 29(1):48-53. PubMed ID: 32282391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States.
    Bisognano J; Schneider JE; Davies S; Ohsfeldt RL; Galle E; Stojanovic I; Deering TF; Lindenfeld J; Zile MR
    BMC Cardiovasc Disord; 2021 Mar; 21(1):155. PubMed ID: 33771104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of diastolic dysfunction in patients with systolic dysfunction undergoing atrial fibrillation ablation.
    Koike T; Ejima K; Kataoka S; Yazaki K; Higuchi S; Kanai M; Yagishita D; Shoda M; Hagiwara N
    Int J Cardiol Heart Vasc; 2022 Aug; 41():101079. PubMed ID: 35812132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baroreceptor stimulation in a patient with preexisting subcutaneous implantable cardioverter defibrillator.
    Weipert KF; Andrick J; Chasan R; Gemein C; Most A; Hamm CW; Erkapic D; Schmitt J
    Pacing Clin Electrophysiol; 2018 Jan; 41(1):90-92. PubMed ID: 28543399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
    Weaver FA; Abraham WT; Little WC; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Madershahian N; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Zile MR
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):320-328. PubMed ID: 28043438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.
    Gronda E; Seravalle G; Brambilla G; Costantino G; Casini A; Alsheraei A; Lovett EG; Mancia G; Grassi G
    Eur J Heart Fail; 2014 Sep; 16(9):977-83. PubMed ID: 25067799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparative Review of Vagal Nerve Stimulation Versus Baroreceptor Activation Therapy in Cardiac Diseases.
    Arya AV; Bisht H; Tripathi A; Agrawal M; Konat A; Patel J; Mozumder K; Shah D; Chaturvedi D; Sharma K
    Cureus; 2023 Jun; 15(6):e40889. PubMed ID: 37492836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany.
    Borisenko O; Müller-Ehmsen J; Lindenfeld J; Rafflenbeul E; Hamm C
    BMC Cardiovasc Disord; 2018 Aug; 18(1):163. PubMed ID: 30092774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote monitoring: Doomed to let down or an attractive promise?
    Lucà F; Cipolletta L; Di Fusco SA; Iorio A; Pozzi A; Rao CM; Ingianni N; Benvenuto M; Madeo A; Fiscella D; Benedetto D; Francese GM; Gelsomino S; Zecchin M; Gabrielli D; Gulizia MM
    Int J Cardiol Heart Vasc; 2019 Sep; 24():100380. PubMed ID: 31193998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure-HFrEF.
    Naser N; Durak-Nalbantic A; Sabanovic-Bajramovic N; Karic A
    Med Arch; 2023 Apr; 77(2):105-111. PubMed ID: 37260796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baroreflex activation for the treatment of heart failure.
    Sabbah HN
    Curr Cardiol Rep; 2012 Jun; 14(3):326-33. PubMed ID: 22528555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.